Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Neuropharmacology|June 30, 2006
The muscle relaxant thiocolchicoside is an antagonist of GABAA receptor function in the central nervous systemMario Carta, Luca Murru, Paolo Botta, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|March 12, 2013
Primary motor cortex hyperexcitability in Fabry's diseaseEnzo Ortu, Laura Fancellu, GianFranco Sau, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 23, 2003
Effects of topiramate in patients with cerebellar tremorGianPietro Sechi, Virgilio Agnetti, Franca M I Sulas, et al.
Parkinsonism & Related Disorders|April 20, 2007
Restless legs syndrome and periodic limb movements after ischemic stroke in the right lenticulostriate regionGianPietro Sechi, Virgilio Agnetti, Paola Galistu, et al.
Parkinsonism & Related Disorders|June 2, 2006
Three sisters with very-late-onset major depression and parkinsonismGianPietro Sechi, Giovanni Antonio Cocco, Alessandra Errigo, et al.
Frontiers in Pharmacology|December 24, 2021
Beneficial Effect of Phenytoin and Carbamazepine on GFAP Gene Expression and Mutant GFAP Folding in a Cellular Model of Alexander's DiseaseTiziana Bachetti, Eleonora Di Zanni, Annalisa Adamo, et al.
Experimental Cell Research|May 18, 2010
In vitro treatments with ceftriaxone promote elimination of mutant glial fibrillary acidic protein and transcription down-regulationTiziana Bachetti, Eleonora Di Zanni, Pietro Balbi, et al.
Biochimica Et Biophysica Acta. General Subjects|March 11, 2018
Chaperone-like effect of ceftriaxone on HEWL aggregation: A spectroscopic and computational studyPaolo Ruzza, Rosa Maria Vitale, Rohanah Hussain, et al.
Data in Brief|June 16, 2018
Spectroscopy data of ceftriaxone-lysozyme interaction and computational studiesPaolo Ruzza, Rosa Maria Vitale, Rohanah Hussain, et al.
Pageof 4